LL-37
The only human cathelicidin — a 37-residue antimicrobial and immunomodulatory peptide.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| 375 | 5 mg | 10 vials / box |
Order LL-37
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
LL-37 is the sole human member of the cathelicidin family of antimicrobial peptides, cleaved from the precursor hCAP18. It is an amphipathic α-helical peptide expressed by neutrophils, epithelial cells and keratinocytes.
Beyond direct broad-spectrum antimicrobial activity, LL-37 is characterised as a chemoattractant, an inducer of angiogenesis and a modulator of wound repair and innate immune signalling 1.
At a glance
- Human cathelicidin antimicrobial peptide
- Studied in wound healing, biofilm and innate-immunity models
- 5 mg vials
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Sequence
- LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
- Formula
- C205H340N60O53
- Mol. weight
- 4493.3 g/mol
- CAS No.
- 154947-66-7
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Dürr UH, Sudheendra US, Ramamoorthy A LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006;1758(9):1408-25.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Often ordered together
Thymosin Alpha-1
28-residue thymic peptide and approved immunomodulator with a comprehensive clinical literature.